- Home
- TENX vs ASBP Comparison
TENX vs ASBP Comparison
Compare TENX & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TENX
- ASBP
- Stock Information
- Founded
- TENX 1967
- ASBP 2021
- Country
- TENX United States
- ASBP United States
- Employees
- TENX N/A
- ASBP N/A
- Industry
- TENX Biotechnology: Pharmaceutical Preparations
- ASBP Biotechnology: Pharmaceutical Preparations
- Sector
- TENX Health Care
- ASBP Health Care
- Exchange
- TENX Nasdaq
- ASBP Nasdaq
- Market Cap
- TENX 21.6M
- ASBP 17.6M
- IPO Year
- TENX N/A
- ASBP N/A
- Fundamental
- Price
- TENX $5.68
- ASBP $0.24
- Analyst Decision
- TENX Strong Buy
- ASBP
- Analyst Count
- TENX 3
- ASBP 0
- Target Price
- TENX $16.00
- ASBP N/A
- AVG Volume (30 Days)
- TENX 12.6K
- ASBP 363.3K
- Earning Date
- TENX 05-14-2025
- ASBP 05-24-2025
- Dividend Yield
- TENX N/A
- ASBP N/A
- EPS Growth
- TENX N/A
- ASBP N/A
- EPS
- TENX N/A
- ASBP N/A
- Revenue
- TENX N/A
- ASBP N/A
- Revenue This Year
- TENX N/A
- ASBP N/A
- Revenue Next Year
- TENX N/A
- ASBP N/A
- P/E Ratio
- TENX N/A
- ASBP N/A
- Revenue Growth
- TENX N/A
- ASBP N/A
- 52 Week Low
- TENX $2.77
- ASBP $0.32
- 52 Week High
- TENX $7.89
- ASBP $15.80
- Technical
- Relative Strength Index (RSI)
- TENX 49.30
- ASBP N/A
- Support Level
- TENX $5.49
- ASBP N/A
- Resistance Level
- TENX $5.87
- ASBP N/A
- Average True Range (ATR)
- TENX 0.27
- ASBP 0.00
- MACD
- TENX 0.03
- ASBP 0.00
- Stochastic Oscillator
- TENX 52.04
- ASBP 0.00
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
About ASBP Aspire Biopharma Holdings Inc. Common Stock
Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.